Thromb Haemost 1995; 73(04): 731-732
DOI: 10.1055/s-0038-1653854
Letters to the Editor
Schattauer GmbH Stuttgart

Apparent Heterozygous Type II Protein C Deficiency Caused by the Factor V 506 Arg to GIn Mutation

Helen Ireland
1   Charing Cross and Westminster Medical School, London UK
,
Trevor Bayston
1   Charing Cross and Westminster Medical School, London UK
,
Elizabeth Thompson
1   Charing Cross and Westminster Medical School, London UK
,
Antonella Adami
1   Charing Cross and Westminster Medical School, London UK
,
Cristina Gonçalves
1   Charing Cross and Westminster Medical School, London UK
,
David A Lane
1   Charing Cross and Westminster Medical School, London UK
,
Guido Finazzi
2   Ospedali Riuntiti di Bergamo, Italy
,
Tiziano Barbui
2   Ospedali Riuntiti di Bergamo, Italy
› Author Affiliations
Further Information

Publication History

Received 28 November 1994

Accepted 13 December 1994

Publication Date:
26 July 2018 (online)

 
  • References

  • 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad USA 1993; 90: 1004-1008
  • 2 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van deVeldon, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
  • 3 Faioni EM, Franchi F, Asti D, Sacchi E, Bemardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilie families: interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-1071
  • 4 Faioni EM, Boyer-Neumann C, Franchi F, Wolff M, Meyer D, Mannucci PM. Another Protein S functional assay is sensitive to resistance to activated Protein C. Thromb Haemost 1994; 72: 648